IN2014KN02647A - - Google Patents

Info

Publication number
IN2014KN02647A
IN2014KN02647A IN2647KON2014A IN2014KN02647A IN 2014KN02647 A IN2014KN02647 A IN 2014KN02647A IN 2647KON2014 A IN2647KON2014 A IN 2647KON2014A IN 2014KN02647 A IN2014KN02647 A IN 2014KN02647A
Authority
IN
India
Prior art keywords
aptamer
target
kits
nucleic acid
detection
Prior art date
Application number
Inventor
Glenn Sanders
Stephan Kraemer
Evaldas Katilius
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of IN2014KN02647A publication Critical patent/IN2014KN02647A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/205—Aptamer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes

Abstract

The present disclosure describes methods, devices, reagents, and kits for the detection of one or more target molecules that may be present in a test sample. The described methods, devices, kits, and reagents facilitate the detection and quantification of a non-nucleic acid target (e.g., a protein target) in a test sample by detecting and quantifying a nucleic acid (i.e., an aptamer) where the aptamer-aptamer interactions are significantly reduced or eliminated while maintaining the aptamer-target interaction.
IN2647KON2014 2012-06-07 2013-06-07 IN2014KN02647A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261656956P 2012-06-07 2012-06-07
PCT/US2013/044792 WO2013185078A1 (en) 2012-06-07 2013-06-07 Aptamer-based multiplexed assays

Publications (1)

Publication Number Publication Date
IN2014KN02647A true IN2014KN02647A (en) 2015-05-08

Family

ID=49712701

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2647KON2014 IN2014KN02647A (en) 2012-06-07 2013-06-07

Country Status (22)

Country Link
US (4) US20150141259A1 (en)
EP (1) EP2859121B1 (en)
JP (1) JP6298456B2 (en)
KR (1) KR102088381B1 (en)
CN (2) CN104508150B (en)
AU (1) AU2013271401B2 (en)
BR (1) BR112014030298B1 (en)
CA (1) CA2873099C (en)
CY (1) CY1118748T1 (en)
ES (1) ES2617226T3 (en)
HK (1) HK1204341A1 (en)
HR (1) HRP20170296T1 (en)
IL (1) IL235588B (en)
IN (1) IN2014KN02647A (en)
MX (1) MX356413B (en)
MY (1) MY170164A (en)
NZ (1) NZ701824A (en)
PH (1) PH12014502581A1 (en)
RU (1) RU2666989C2 (en)
SG (2) SG11201407505XA (en)
WO (1) WO2013185078A1 (en)
ZA (1) ZA201408409B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110136099A1 (en) 2007-01-16 2011-06-09 Somalogic, Inc. Multiplexed Analyses of Test Samples
US8975026B2 (en) 2007-01-16 2015-03-10 Somalogic, Inc. Method for generating aptamers with improved off-rates
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
CN106133211A (en) * 2014-01-14 2016-11-16 爱普济德生物技术有限公司 Nucleic acid reagent for carrying out hypersensitive Digital Detecting and quantitative purposes to target molecule
CN116334088A (en) 2014-02-18 2023-06-27 私募蛋白质体运营有限公司 Compositions and methods for detecting microorganisms
EP3146337B1 (en) * 2014-05-23 2020-05-27 Firefly Bioworks, Inc. Substrate-mediated reactors for bioassays
GB2528643A (en) * 2014-07-08 2016-02-03 Adc Biotechnology Ltd Method of synthesising ADCs
KR102003589B1 (en) * 2016-03-03 2019-07-24 성균관대학교산학협력단 Bid molecule detection sensor and method for detecting specific molecule using multi-wavelength fluorescence
CN105779609A (en) * 2016-04-15 2016-07-20 上海伊丽萨生物科技有限公司 Hypersensitivity immunodetection method
CA3039057A1 (en) * 2016-10-13 2018-04-19 Laboratory Corporation Of America Holdings Devices and methods to reduce interfering compounds in biological samples
US20190317082A1 (en) * 2018-04-13 2019-10-17 Fluidigm Canada Inc. Stabilized cell acquisition for elemental analysis
JP2021528646A (en) * 2018-06-22 2021-10-21 ソマロジック・インコーポレーテッド Improved proteomics multiplex assay
US11181501B2 (en) 2018-09-11 2021-11-23 City University Of Hong Kong Method and an apparatus for determining a presence or an amount of a polyamine or its derivative in a sample
LU101073B1 (en) * 2018-12-21 2020-06-24 Luxembourg Inst Science & Tech List Dna aptamers specific of adenovirus types
KR102177672B1 (en) * 2019-02-01 2020-11-12 주식회사 압타머사이언스 Multiplex PCR method using Aptamer
KR102113078B1 (en) * 2019-07-05 2020-05-20 광주과학기술원 A screening method of aptamer
CN110791551A (en) * 2019-09-17 2020-02-14 北京化工大学 Method for establishing carrier-free chloramphenicol aptamer signal amplification sensor
WO2021112559A1 (en) * 2019-12-03 2021-06-10 김성천 Method for obtaining profile of target molecule population of sample
CN113624724A (en) * 2020-05-07 2021-11-09 廖世奇 Multi-element detection and analysis method of aptamer molecular beacon for target molecule
CN111812313B (en) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 Dissociation method of antigen in aluminum adjuvant adsorption type novel coronavirus inactivated vaccine
US11578320B2 (en) 2021-04-27 2023-02-14 Singular Genomics Systems, Inc. High density sequencing and multiplexed priming
KR20220167781A (en) * 2021-06-14 2022-12-21 김성천 Method for Obtaining Profiles for Population of Target Protein Molecules of a Sample Using Aptamers

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2259800T3 (en) 1990-06-11 2006-10-16 Gilead Sciences, Inc. PROCEDURES FOR THE USE OF NUCLEIC ACID LINKS.
US6242246B1 (en) 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
PL202358B1 (en) * 1999-11-17 2009-06-30 Roche Diagnostics Gmbh Magnetic glass particles, method for their preparation and uses thereof
US7601497B2 (en) * 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
DE60326864D1 (en) 2002-07-24 2009-05-07 Bio Rad Laboratories PROTEIN INTERACTION DIFFERENCE PICTURE
RU2361193C2 (en) * 2004-05-19 2009-07-10 Вп Холдинг, Ллс Optical sensor with multilayered plasmon structure for improved detection of chemical groups through sers
US7699979B2 (en) * 2005-01-07 2010-04-20 Board Of Trustees Of The University Of Arkansas Separation system and efficient capture of contaminants using magnetic nanoparticles
US7285835B2 (en) * 2005-02-24 2007-10-23 Freescale Semiconductor, Inc. Low power magnetoelectronic device structures utilizing enhanced permeability materials
EP1918372A4 (en) * 2005-07-05 2009-08-12 Ribomic Inc Nucleic acid capable of binding to immunoglobulin g and use thereof
EP1994171B1 (en) * 2006-01-17 2015-03-11 Somalogic, Inc. Multiplexed analyses of test samples
US7855054B2 (en) * 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US7964356B2 (en) 2007-01-16 2011-06-21 Somalogic, Inc. Method for generating aptamers with improved off-rates
US7947447B2 (en) * 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
EP2336314A1 (en) * 2007-07-17 2011-06-22 Somalogic, Inc. Improved selex and photoselex
US8291501B2 (en) * 2008-02-08 2012-10-16 Cheng Holdings, Llc Validation of protected intra-system interconnects for digital rights management in electrical computers and digital data processing systems
US20110120487A1 (en) * 2008-05-30 2011-05-26 L'oreal Hair treatment methods and kits
AU2009273052B2 (en) * 2008-07-14 2015-09-17 The University Of Tokyo Aptamer against IL-17 and use thereof
US9089152B2 (en) * 2009-04-13 2015-07-28 TEAGASC—Agriculture and Food Development Authority Method of producing microbeads
GB0916700D0 (en) * 2009-09-23 2009-11-04 Nanoco Technologies Ltd Semiconductor nanoparticle-based materials

Also Published As

Publication number Publication date
BR112014030298B1 (en) 2022-09-27
ZA201408409B (en) 2017-08-30
PH12014502581B1 (en) 2015-01-21
CN104508150B (en) 2021-03-12
US20180224444A1 (en) 2018-08-09
KR20150030655A (en) 2015-03-20
MX356413B (en) 2018-05-29
RU2666989C2 (en) 2018-09-13
AU2013271401B2 (en) 2018-04-05
BR112014030298A2 (en) 2017-06-27
EP2859121A1 (en) 2015-04-15
US20150141259A1 (en) 2015-05-21
CN108614102A (en) 2018-10-02
IL235588B (en) 2018-07-31
EP2859121B1 (en) 2016-11-30
SG10201701361WA (en) 2017-04-27
PH12014502581A1 (en) 2015-01-21
EP2859121A4 (en) 2015-12-16
CA2873099C (en) 2021-06-15
MY170164A (en) 2019-07-09
AU2013271401A1 (en) 2014-11-27
US20170176422A1 (en) 2017-06-22
KR102088381B1 (en) 2020-03-13
IL235588A0 (en) 2015-01-29
HK1204341A1 (en) 2015-11-13
CY1118748T1 (en) 2017-07-12
US20210239692A1 (en) 2021-08-05
WO2013185078A1 (en) 2013-12-12
CA2873099A1 (en) 2013-12-12
CN104508150A (en) 2015-04-08
BR112014030298A8 (en) 2022-03-08
HRP20170296T1 (en) 2017-04-21
ES2617226T3 (en) 2017-06-15
JP2015520385A (en) 2015-07-16
NZ701824A (en) 2017-01-27
MX2014014784A (en) 2015-03-19
ES2617226T8 (en) 2019-08-27
SG11201407505XA (en) 2014-12-30
RU2014152698A (en) 2016-08-10
JP6298456B2 (en) 2018-03-20

Similar Documents

Publication Publication Date Title
PH12014502581A1 (en) Aptamer-based mulitiplexed assays
MX341491B (en) Multiplexed analyses of test samples.
MX2020004617A (en) Cardiovascular risk event prediction and uses thereof.
GB201200658D0 (en) Methods,compositions,and kits for determining the presence/absence of a variant nucleic acid sequence
EP3862439A3 (en) Liver cancer detection kit or device, and detection method
EP3757225A3 (en) Pancreatic cancer detection kit or device, and detection method
IN2014DN09493A (en)
WO2012004790A3 (en) Nucleic acid aptamer-based detection methods characterized by signal enhancement
EP3654036A3 (en) Stomach cancer biomarker and detection method
MX338296B (en) Compositions and methods for quantifying a nucleic acid sequence in a sample.
EA030186B9 (en) Method for performing quantitation assays
IN2014CN03508A (en)
WO2014186761A3 (en) Methods for determining responsiveness to an anti-cd47 agent
MX2015001961A (en) Assay methods and systems.
EP2254897A4 (en) Methods, reagents and kits for detection of nucleic acid molecules
EP3216852A4 (en) Method for introducing nucleic acid, method for detecting nucleic acid, method for analyzing biological component, array device for biological component assay, and kit for analyzing biological component
GB2515944A (en) Peptide arrays
MX2015012319A (en) Analytical instrument systems.
WO2013090386A3 (en) Methods and kits for room temperature in situ detection of a target nucleic acid in a biological sample
GB2542576A (en) Method and kit of detecting the absence of micro-oranisms
WO2013166444A3 (en) Biomarker analysis using scodaphoresis
MX2015004419A (en) Detecting an analyte and determining the concentration of an analyte using magnetizable beads.
EP3208333A4 (en) Method for detecting and quantifying target nucleic acid in test sample using novel positive control nucleic acid
EP4282961A3 (en) Compositions and methods for the detection and analysis of mycobacterium tuberculosis
MY182547A (en) Polymerase chain reaction detection system